Antiphospholipid antibodies associated with malignancies: clinical and pathological characteristics of 120 patients.
about
Clinical and serological follow-up of 71 patients with anti-mitochondrial type 5 antibodies.Thromboembolic and bleeding complications in acute leukemia.Acquired immune-mediated thrombophilia in lymphoproliferative disorders.Multiple autoimmune propensity and B-non-hodgkin lymphoma: cause or effect?Catastrophic antiphospholipid syndrome associated with malignancies (case report and review of the literature).Antiphospholipid syndrome and vascular ischemic (occlusive) diseases: an overview.Serologic laboratory findings in malignancy.The association between ABO blood types and venous thromboembolism in individuals with a positive antiphospholipid profile is varied by sex.The antiphospholipid syndrome: from pathophysiology to treatment.Late-onset primary antiphospholipid syndrome in the elderly: a report of seven cases.Development and validation of multivariable predictive model for thromboembolic events in lymphoma patients.Severe digital ischemia-a presenting symptom of malignancy-associated antiphospholipid syndrome.Inflammation and Hemostatic Activation may Contribute to Postsurgical Thrombosis in Patients With Bladder Cancer.Pediatric antiphospholipid syndrome.Splenomegaly in primary antiphospholipid syndrome without accompanying portal hypertension or comorbidity.Clotting, immune system, and venous thrombosis in lung adenocarcinoma patients: a prospective study.Management of phenytoin-induced gingival enlargement in a patient with antiphospholipid antibody syndrome: A rare case report.Impact of Classical Risk Factors for Arterial or Venous Thrombosis in Patients With Antiphospholipid Syndrome.Elevated levels of serum IgM anti-phosphatidylserine-prothrombin complex antibodies in patients with cancer-associated vasculitis.Neuroendocrine manifestations of phospholipid antibody disease identified by long-term follow-up study of patients with phospholipid antibodies
P2860
Q33376802-5362D896-C3E7-49CF-BC12-3E181D124051Q33392897-61D5745E-8BBA-4EB4-A636-692EFC5469ACQ33396280-3D3B6CC4-E18E-4441-933E-10D2000FF9F2Q35038847-BEFF9AE6-F791-472B-B28D-3F9848A80CDDQ36729464-FD73B183-5A79-4FBB-8C09-7EF83E6FD957Q37045158-D62B83CF-53D1-4C8A-87C4-31B7E75F3FBDQ37401677-6D8F51DC-57EF-4E59-8C1A-4ECB79554FF6Q38680580-80D17524-860A-4229-98A7-719E9B7E4BACQ38873953-5608F2C4-24C6-4B20-9E17-08150FCD08C7Q38943431-F8A2D384-FEF1-4F63-934B-FA7C21865244Q39629675-8981EC5C-9D23-4CA2-BC57-EA84167CCD1BQ39841022-D42E8CF3-3886-4E31-8ADD-895340ED18D8Q40191314-2B2B226F-AB37-401A-AFB3-CF2C9F310325Q41100232-B20EE649-7277-4D92-94D9-C002167DF480Q42740740-95642F59-836F-4EA4-8DDF-0D44BD7162ECQ43411494-3EF3F040-1A45-4D5D-B4B2-4DAA7FA177C6Q45913321-EF1F3E04-0830-41B8-B8D1-8DD50D834B27Q47705471-51388E83-65C3-474A-B99B-365F53BFCB60Q52602305-B39DA385-5636-4F13-9B6B-EA347975882DQ57647720-1D951402-93F5-4BC9-9E7E-35B1042B66D2
P2860
Antiphospholipid antibodies associated with malignancies: clinical and pathological characteristics of 120 patients.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Antiphospholipid antibodies as ...... aracteristics of 120 patients.
@ast
Antiphospholipid antibodies as ...... aracteristics of 120 patients.
@en
type
label
Antiphospholipid antibodies as ...... aracteristics of 120 patients.
@ast
Antiphospholipid antibodies as ...... aracteristics of 120 patients.
@en
prefLabel
Antiphospholipid antibodies as ...... aracteristics of 120 patients.
@ast
Antiphospholipid antibodies as ...... aracteristics of 120 patients.
@en
P50
P1476
Antiphospholipid antibodies as ...... aracteristics of 120 patients.
@en
P2093
Silvia Bucciarelli
Sira Aguiló
P304
P356
10.1016/J.SEMARTHRIT.2005.07.003
P50
P577
2006-04-01T00:00:00Z